TD Asset Management’s RAPT Therapeutics RAPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-12,262
| Closed | -$24K | – | 1376 |
|
2024
Q3 | $24K | Hold |
12,262
| – | – | ﹤0.01% | 1378 |
|
2024
Q2 | $37.4K | Hold |
12,262
| – | – | ﹤0.01% | 1354 |
|
2024
Q1 | $110K | Sell |
12,262
-105,356
| -90% | -$946K | ﹤0.01% | 1371 |
|
2023
Q4 | $2.92M | Sell |
117,618
-36,000
| -23% | -$895K | ﹤0.01% | 888 |
|
2023
Q3 | $2.55M | Buy |
153,618
+61,831
| +67% | +$1.03M | ﹤0.01% | 890 |
|
2023
Q2 | $1.72M | Sell |
91,787
-1,701
| -2% | -$31.8K | ﹤0.01% | 1001 |
|
2023
Q1 | $1.72M | Hold |
93,488
| – | – | ﹤0.01% | 1018 |
|
2022
Q4 | $1.85M | Sell |
93,488
-2,845
| -3% | -$56.3K | ﹤0.01% | 1012 |
|
2022
Q3 | $2.3M | Hold |
96,333
| – | – | ﹤0.01% | 962 |
|
2022
Q2 | $1.76M | Sell |
96,333
-1,712
| -2% | -$31.2K | ﹤0.01% | 1046 |
|
2022
Q1 | $2.16M | Sell |
98,045
-10,498
| -10% | -$231K | ﹤0.01% | 1068 |
|
2021
Q4 | $3.99M | Buy |
108,543
+24,903
| +30% | +$915K | ﹤0.01% | 928 |
|
2021
Q3 | $2.6M | Buy |
83,640
+5,800
| +7% | +$180K | ﹤0.01% | 1008 |
|
2021
Q2 | $2.39M | Buy |
77,840
+13,121
| +20% | +$402K | ﹤0.01% | 1039 |
|
2021
Q1 | $1.44M | Buy |
64,719
+3,557
| +6% | +$79K | ﹤0.01% | 1183 |
|
2020
Q4 | $1.21M | Buy |
61,162
+3,192
| +6% | +$63K | ﹤0.01% | 1139 |
|
2020
Q3 | $1.87M | Buy |
57,970
+31,200
| +117% | +$1M | ﹤0.01% | 925 |
|
2020
Q2 | $777K | Buy |
26,770
+11,072
| +71% | +$321K | ﹤0.01% | 1121 |
|
2020
Q1 | $334K | Buy |
15,698
+2,810
| +22% | +$59.8K | ﹤0.01% | 1253 |
|
2019
Q4 | $356K | Buy |
+12,888
| New | +$356K | ﹤0.01% | 1294 |
|